FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component

48798 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Existential restriction modifier (core metadata concept)
Members targetComponentId
Benzoyl peroxide 10% Benzoyl peroxide-containing product
Benzoyl peroxide 10% Benzoyl peroxide-containing product
Benzoyl peroxide 10% wash Product containing only benzoyl peroxide in cutaneous dose form (medicinal product form)
Benzoyl peroxide 10% wash Product containing only benzoyl peroxide in cutaneous dose form (medicinal product form)
Benzoyl peroxide 2.5% + clindamycin 1.2% topical gel Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug)
Benzoyl peroxide 2.5% + clindamycin 1.2% topical gel Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug)
Benzoyl peroxide 8% cream Product containing only benzoyl peroxide in cutaneous dose form (medicinal product form)
Benzoyl peroxide 8% cream Product containing only benzoyl peroxide in cutaneous dose form (medicinal product form)
Benzoyl peroxide 8% cutaneous cream Product containing only benzoyl peroxide in cutaneous dose form (medicinal product form)
Benzoyl peroxide 8% cutaneous cream Product containing only benzoyl peroxide in cutaneous dose form (medicinal product form)
Benzquinamide 50mg injection solution vial Benzquinamide 25 mg/mL solution for injection
Benzquinamide 50mg injection solution vial Benzquinamide 25 mg/mL solution for injection
Benzyl penicilloyl-polylysin 0.06mcm/.25mL Benzylpenicilloyl polylysine only product in parenteral dose form
Benzyl penicilloyl-polylysin 0.06mcm/.25mL Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection solution 0.25mL syringe
Benzyl penicilloyl-polylysin 0.06mcm/.25mL Benzylpenicilloyl polylysine only product in parenteral dose form
Benzyl penicilloyl-polylysin 0.06mmo injection Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection solution 0.25mL syringe
Benzyl penicilloyl-polylysin 0.06mmo injection Benzylpenicilloyl polylysine only product in parenteral dose form
Benzyl penicilloyl-polylysin 0.06mmo injection Benzylpenicilloyl polylysine only product in parenteral dose form
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection Benzylpenicilloyl polylysine only product in parenteral dose form
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection solution 0.25mL syringe
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection Benzylpenicilloyl polylysine only product in parenteral dose form
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection solution 0.25mL syringe Benzylpenicilloyl polylysine only product in parenteral dose form
Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection solution 0.25mL syringe Benzylpenicilloyl polylysine only product in parenteral dose form
Beractant 100mg intratracheal suspension 4mL vial Phospholipid (as beractant) 25 mg/mL suspension for endotracheopulmonary instillation
Beractant 100mg intratracheal suspension 4mL vial Phospholipid (as beractant) 25 mg/mL suspension for endotracheopulmonary instillation
virus Berne Equine torovirus (organism)
Betaherpesvirus group Subfamily Betaherpesvirinae (organism)
Betaherpesvirus group Subfamily Betaherpesvirinae (organism)
Betaine, anhydrous 1g/scp powder Betaine only product
Betaine, anhydrous 1g/scp powder Betaine only product
Betamethasone 0.1% cream (substance) Betamethasone valerate 1 mg/mL cutaneous cream
Betamethasone 0.1% cream (substance) Betamethasone valerate 1 mg/mL cutaneous cream
Betamethasone 0.1% lotion Product containing precisely betamethasone valerate 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)
Betamethasone 0.1% lotion Product containing precisely betamethasone valerate 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)
Betamethasone 0.1% ointment Betamethasone valerate 1 mg/g cutaneous ointment
Betamethasone 0.1% ointment Betamethasone valerate 1 mg/g cutaneous ointment
Betamethasone 0.6mg/5mL syrup Betamethasone 120 microgram/mL oral solution
Betamethasone 0.6mg/5mL syrup Betamethasone 120 microgram/mL oral solution
Betamethasone 500micrograms soluble tablet (substance) Product containing precisely betamethasone 500 microgram/1 each conventional release orodispersible tablet (clinical drug)
Betamethasone 500micrograms soluble tablet (substance) Product containing precisely betamethasone 500 microgram/1 each conventional release orodispersible tablet (clinical drug)
Betamethasone acetate + betamethasone sodium phospha 3mg/ns soluspan Betamethasone only product in parenteral dose form
Betamethasone acetate + betamethasone sodium phospha 3mg/ns soluspan Betamethasone only product in parenteral dose form
Betamethasone acetate + betamethasone sodium phosphate 3mg/3mg per mL injection suspension Betamethasone only product in parenteral dose form
Betamethasone acetate + betamethasone sodium phosphate 3mg/3mg per mL injection suspension Betamethasone only product in parenteral dose form
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)
Betamethasone dipropionate 0.05% gel Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug)
Betamethasone dipropionate 0.05% gel Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug)
Betamethasone dipropionate 0.05% lotion Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)
Betamethasone dipropionate 0.05% lotion Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)
Betamethasone dipropionate0.5% ointment (product) Product containing precisely betamethasone (as betamethasone dipropionate) 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)
Betamethasone dipropionate0.5% ointment (product) Product containing precisely betamethasone (as betamethasone dipropionate) 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)
Betamethasone dipropionate 0.5mg cream Betamethasone 0.05% cream (substance)
Betamethasone dipropionate 0.5mg cream Betamethasone 0.05% cream (substance)
Betamethasone dipropionate 0.5mg/g cream Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream
Betamethasone dipropionate 0.5mg/g cream Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream
Betamethasone dipropionate 0.5mg/g ointment Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug)
Betamethasone dipropionate 0.5mg/g ointment Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment
Betamethasone dipropionate 0.5mg/g ointment Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment
Betamethasone sodium phospha 15mg/5mL injection Betamethasone sodium phospha 3mg/mL injection solution 5mL vial
Betamethasone sodium phospha 4mg/mL injection Betamethasone sodium phosphate 4mg/mL injection solution 5mL vial
Betamethasone+clotrimazole 0.05/1% cream Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)
Betamethasone+clotrimazole 0.05/1% cream Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug)
Betaxolol 0.25% conventional release eye drops Betaxolol 0.25% eye drops (substance)
Betaxolol 0.25% conventional release eye drops Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug)
Betaxolol 0.25% conventional release eye drops Betaxolol 0.25% eye drops (substance)
Betaxolol 0.25% single-use eye drops Betaxolol 0.25% eye drops (substance)
Betaxolol 0.25% single-use eye drops Betaxolol 0.25% eye drops (substance)
Betaxolol 0.25% single-use eye drops Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug)
Bi-layered skin substitute 75millimeter diameter circular disk Bioengineered graft of skin
Bi-layered skin substitute 75millimeter diameter circular disk Bioengineered graft of skin
Bi-layered skin substitute from keratinocytes and fibroblasts Bi-layered skin substitute from keratinocytes and fibroblasts
Bi-layered skin substitute from keratinocytes and fibroblasts Bi-layered skin substitute from keratinocytes and fibroblasts
Bicaulus Varestrongylus
Bicaulus Varestrongylus
Bicaulus schulzi Varestrongylus
Bicaulus schulzi Varestrongylus
radiographie du sillon intertuberculaire de l'humérus Plain X-ray of bicipital groove (procedure)
radiographie du sillon intertuberculaire de l'humérus Plain X-ray of bicipital groove (procedure)
utérus bicorne affectant les soins obstétricaux Bicornuate uterus in pregnancy, childbirth and the puerperium
utérus bicorne affectant les soins obstétricaux Bicornuate uterus in pregnancy, childbirth and the puerperium
Bifidobacterium suis Bifidobacterium longum
Bifidobacterium suis Bifidobacterium longum
Big big gastrin Gastrin-71
Big big gastrin Gastrin-71
Bilateral complete and incomplete cleft lip and/or alveolus Congenital anomaly of mouth
Bilateral complete and incomplete cleft lip and/or alveolus Congenital anomaly of mouth
Bilateral developmental dislocation Bilateral congenital dislocation
Bilateral developmental dislocation Congenital dislocation
Bilateral femoral hernia with obstruction but no gangrene Obstructed bilateral femoral hernia (disorder)
Bilateral femoral hernia with obstruction but no gangrene Obstructed bilateral femoral hernia (disorder)
Bilateral hyperplasia Hyperplasia
Bilateral hyperplasia Hyperplasia
Bilateral hypoplasia Hypoplasia
Bilateral hypoplasia Hypoplasia
Bilateral partial developmental dislocation Partial congenital dislocation
Bilateral partial developmental dislocation Bilateral partial congenital dislocation
Bilateral right-sidedness sequence A rare heterotaxia characterised by complex congenital heart malformations and abnormal lateralisation of other thoracic and abdominal organs due to embryonic disruption of the left-right axis development. Cardiac defects include dextrocardia or mesocardia, common atrioventricular valve associated with complete atrioventricular septal defect or common atrium, transposition or malposition of the great arteries, and total anomalous pulmonary venous drainage, among others. Cardiac arrhythmias are frequently observed. Typical abnormalities of other organs are bilateral trilobed lungs, midline liver, and asplenia. Patients present in the newborn period with severe cardiac failure and cyanosis. Prognosis is poor.
Bilateral right-sidedness sequence A rare heterotaxia characterised by complex congenital heart malformations and abnormal lateralisation of other thoracic and abdominal organs due to embryonic disruption of the left-right axis development. Cardiac defects include dextrocardia or mesocardia, common atrioventricular valve associated with complete atrioventricular septal defect or common atrium, transposition or malposition of the great arteries, and total anomalous pulmonary venous drainage, among others. Cardiac arrhythmias are frequently observed. Typical abnormalities of other organs are bilateral trilobed lungs, midline liver, and asplenia. Patients present in the newborn period with severe cardiac failure and cyanosis. Prognosis is poor.
Bilateral traumatic amputation Traumatic amputation
amputation traumatique bilatérale des membres supérieurs à n'importe quel niveau avec complication Bilateral traumatic amputation of upper limbs

Start Previous Page 47 of 488 Next End

Reference Sets

Reference set descriptor

Back to Start